Literature DB >> 6776111

Stimulation of arachidonic acid metabolism in the polymorphonuclear leukocyte by an N-formylated peptide. Comparison with ionophore A23187.

G M Bokoch, P W Reed.   

Abstract

Inhibitors of arachidonic acid oxygenation can inhibit polymorphonuclear leukocyte lysosomal enzyme release, aggregation, and generation of activated oxygen species, as stimulated by N-formylated chemotactic peptides. Guinea Guinea pig peritoneal leukocytes were prelabeled with [3H]arachidonic acid, and 6-keto-prostaglandin F1 alpha, thromboxane B2, prostaglandin E2, prostaglandin F2 alpha, and 5-monohydroxyeicosatetraenoic acid were identified as products produced by these cells. Both Ionophore A23187 and the N-formylated peptide, N-formylmethionylphenylalanine, significantly stimulated release of these products, with the exception of a lack of effect of N-formylmethionylphenylalanine on 6-keto-prostaglandin F1 alpha. This metabolite was found to be produced by contaminating mononuclear cells unresponsive to N-formylmethionylphenylalanine stimulation when cell preparations purified to 96 leads to 99% polymorphonuclear cells were studied. The ability of N-formylmethionylphenylalanine to stimulate arachidonic acid metabolism of polymorphonuclear leukocytes was specifically antagonized by a competitive blocker of the formylated peptide receptor, t-butoxy-carbonyl-leucyl-phenylalanyl-leucyl-phenylalanine. The results indicate that metabolism of arachidonic acid induced by N-formylmethionylphneylalanine could play a role in the responses of polymorphonuclear leukocytes to this peptide.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6776111

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  Modulation of leukotriene generation by pertussis toxin.

Authors:  T Hensler; M Raulf; F Megret; J E Alouf; W König
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

Review 2.  Inflammatory intermediaries in inflammatory bowel disease.

Authors:  K Lauritsen; L S Laursen; K Bukhave; J Rask-Madsen
Journal:  Int J Colorectal Dis       Date:  1989       Impact factor: 2.571

3.  Differential control of azurophilic and specific granule exocytosis in Sendai-virus-permeabilized rabbit neutrophils.

Authors:  M M Barrowman; S Cockcroft; B D Gomperts
Journal:  J Physiol       Date:  1987-02       Impact factor: 5.182

4.  Exaggerated atrial arachidonate metabolism in rabbit left ventricular myocardial infarction.

Authors:  A S Evers; C G Dunkel; J E Saffitz; P Needleman
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

5.  Hepoxilin A3 induces changes in cytosolic calcium, intracellular pH and membrane potential in human neutrophils.

Authors:  S Dho; S Grinstein; E J Corey; W G Su; C R Pace-Asciak
Journal:  Biochem J       Date:  1990-02-15       Impact factor: 3.857

6.  Identification of a chloroform-soluble membrane miniprotein in Escherichia coli and its homolog in Salmonella typhimurium.

Authors:  Ziqiang Guan; Xiaoyuan Wang; Christian R H Raetz
Journal:  Anal Biochem       Date:  2010-11-02       Impact factor: 3.365

7.  Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils.

Authors:  W F Stenson; E Lobos
Journal:  J Clin Invest       Date:  1982-02       Impact factor: 14.808

8.  Enhanced neutrophil migration in vivo HLA B27 positive subjects.

Authors:  P Koivuranta-Vaara; H Repo; M Leirisalo; U Kiistala; T Osterman; H Vapaatalo
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

9.  Arachidonic acid metabolism by human monocytes. Studies with platelet-depleted cultures.

Authors:  N A Pawlowski; G Kaplan; A L Hamill; Z A Cohn; W A Scott
Journal:  J Exp Med       Date:  1983-08-01       Impact factor: 14.307

10.  Immune system control of rat and rabbit colonic electrolyte transport. Role of prostaglandins and enteric nervous system.

Authors:  M J Bern; C W Sturbaum; S S Karayalcin; H M Berschneider; J T Wachsman; D W Powell
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.